A murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies.
A murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies.
复制标题
用于评估基于生物材料的局部递送疗法的皮肤曲霉病小鼠模型。
DOI:
10.1002/jbm.a.36671
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Mikos,AntoniosG
中科院分区:
文献类型:
--
作者:
Tatara,AlexanderM;Watson,Emma;Albert,NathanielD;Kontoyiannis,PanayiotisD;Kontoyiannis,DimitriosP;Mikos,AntoniosG
Cutaneous fungal infection is a challenging condition to treat that primarily afflicts immunocompromised patients. Local antifungal therapy may permit the delivery of high concentrations of antifungals directly to wounds while minimizing systemic toxicities. However, the field currently lacks suitablein vivomodels. Therefore, a large cutaneous wound was created in immunosuppressed mice and inoculated withAspergillus fumigatus. We fabricated biodegradable polymer microparticles (MPs) that were capable of locally delivering antifungal and characterizedin vitrorelease kinetics. We compared wound bed size, fungal burden, and histological presence of fungi in mice treated with antifungal‐loaded MPs. Mice with a cutaneous defect but no infection, mice with infected cutaneous defect but no treatment, and infected mice treated with blank MPs were used as controls. Infection of large wounds inhibited healing and resulted in tissue invasion in an inoculum‐dependent manner. MPs were capable of releasing antifungals at concentrations aboveA. fumigatusMinimum Inhibitory Concentration (MIC) for at least 6 days. Wounds treated with MPs had significantly decreased size compared with no treatment (64.2% vs. 19.4% wound reduction,p= 0.002) and were not significantly different from uninfected controls (64.2% vs. 58.1%,p= 0.497). This murine model may serve to better understand cutaneous fungal infection and evaluate local biomaterials‐based therapies. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 1867–1874, 2019.